These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

313 related items for PubMed ID: 10179335

  • 1. Removal of regulations regarding certification of antibiotic drugs; companion document to direct final rule--FDA. Proposed rule.
    Fed Regist; 1998 May 12; 63(91):26127-9. PubMed ID: 10179335
    [Abstract] [Full Text] [Related]

  • 2. Removal of regulations regarding certification of drugs composed wholly or partly of insulin; companion document to direct final rule--FDA. Proposed rule.
    Fed Regist; 1998 May 13; 63(92):26690-3. PubMed ID: 10179340
    [Abstract] [Full Text] [Related]

  • 3. Removal of regulations regarding certification of drugs composed wholly or partly of insulin--FDA. Direct final rule.
    Fed Regist; 1998 May 13; 63(92):26694-9. PubMed ID: 10179341
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Medical devices; reports of corrections and removals--FDA. Direct final rule.
    Fed Regist; 1998 Aug 07; 63(152):42229-33. PubMed ID: 10181725
    [Abstract] [Full Text] [Related]

  • 10. Investigational new drug applications; clinical holds--FDA. Direct final rule.
    Fed Regist; 1998 Dec 14; 63(239):68676-8. PubMed ID: 10187558
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Medical devices; establishment registration and device listing for manufacturers and distributors of devices; companion to direct final rule--FDA. Proposed rule.
    Fed Regist; 1998 Sep 29; 63(188):51874-5. PubMed ID: 10185813
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Medical devices; 30-day notices and 135-day PMA (premarket approval application) supplement review; companion document to direct final rule--FDA. Proposed rule.
    Fed Regist; 1998 Apr 27; 63(80 Pt 1):20558-61. PubMed ID: 10179320
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. General administrative rulings and decisions; amendment to the examination and investigation sample requirements; companion document to direct final rule--FDA. Proposed rule.
    Fed Regist; 1998 Sep 25; 63(186):51322-4. PubMed ID: 10185811
    [Abstract] [Full Text] [Related]

  • 19. Administrative practices and procedures; internal agency review of decisions; companion document to direct final rule--FDA. Proposed rule.
    Fed Regist; 1998 Jun 16; 63(115):32772-4. PubMed ID: 10180279
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.